Skip to Content

Pelican Bidco/Cruinn Diagnostics

M/21/074

Completed

Transaction details

The proposed acquisition of sole control by Pelican Bidco Limited of Cruinn Diagnostics Limited has been cleared by the Competition and Consumer Protection Commission.
Case details
  • Notification date:14 December 2021
  • Publication date:14 December 2021
  • Economic sector:Human health & social work - R
  • Economic sub-sector:Human health activities - R.86
  • Simplified merger:Yes
  • Outcome:Cleared
Documents
Timetable

Phase One

  • Tuesday, 14 December, 2021 Notification received
  • Wednesday, 29 December, 2021 Third party submission deadline
  • Thursday, 30 December, 2021 Determination issued
Parties Involved

Pelican Bidco Limited

Pelican Bidco Limited is a private limited company incorporated in Ireland, and established for the purposes of the Proposed Transaction. It is controlled by funds managed by MML Growth Capital Partners Ireland II Limited. These funds are private equity funds, providing growth capital to private businesses on the island of Ireland for expansion, acquisitions, recapitalisations and shareholder reorganisations.

 

Cruinn Diagnostics Limited

Cruinn is a distributor and supplier of laboratory diagnostic instruments and consumables to customers in the medical, pharmaceutical, independent laboratory and university spaces. Cruinn also undertakes associated services such as maintenance, calibration and some limited laboratory testing. Cruinn is active in the biochemistry, microbiology, haematology and histopathology segments of the market. Cruinn operates from its base in Dublin.

Contacts
View all mergers